CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.

Guo Z, Liu D, Su Z

Open source

DOI
10.1007/s13277-014-2995-5
Published
2015 May
Container
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13277-014-2995-5,
  title = {CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.},
  author = {Guo Z and Liu D and Su Z},
  year = {2015},
  journal = {Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine},
  doi = {10.1007/s13277-014-2995-5},
  url = {https://doi.org/10.1007/s13277-014-2995-5}
}

RIS

TY  - JOUR
TI  - CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
AU  - Guo Z
AU  - Liu D
AU  - Su Z
PY  - 2015
JO  - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
DO  - 10.1007/s13277-014-2995-5
UR  - https://doi.org/10.1007/s13277-014-2995-5
ER  - 

APA

Z, G., D, L., & Z, S. (2015). CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. https://doi.org/10.1007/s13277-014-2995-5

Source records